Advertisement
UK markets close in 11 minutes
  • FTSE 100

    8,070.24
    +29.86 (+0.37%)
     
  • FTSE 250

    19,594.38
    -124.99 (-0.63%)
     
  • AIM

    752.75
    -1.94 (-0.26%)
     
  • GBP/EUR

    1.1654
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2486
    +0.0023 (+0.19%)
     
  • Bitcoin GBP

    50,825.31
    -1,289.31 (-2.47%)
     
  • CMC Crypto 200

    1,373.02
    -9.55 (-0.69%)
     
  • S&P 500

    5,003.42
    -68.21 (-1.34%)
     
  • DOW

    37,830.33
    -630.59 (-1.64%)
     
  • CRUDE OIL

    82.40
    -0.41 (-0.50%)
     
  • GOLD FUTURES

    2,346.50
    +8.10 (+0.35%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,902.60
    -186.10 (-1.03%)
     
  • CAC 40

    8,016.56
    -75.30 (-0.93%)
     

Why BioNTech Rose as Much as 5% Today

Why BioNTech Rose as Much as 5% Today

Coronavirus stock BioNTech (NASDAQ: BNTX) was a winner on Monday. BioNTech announced Monday that it has launched a project aimed at developing a malaria vaccine based on the messenger RNA (mRNA) technology that underpins BNT162b2. The biotech said this program, "will assess multiple vaccine candidates featuring known Malaria targets ... as well as new antigens discovered in the pre-clinical research phase."